Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-06-04

Clinical Trial Update: Effect of Letermovir Prophylaxis on CMV-specific Immune Reconstitution Post UCBT

View source ↗

Summary

A clinical trial evaluating whether Letermovir prophylaxis enhances CMV-specific immune reconstitution after umbilical cord blood transplantation; the study is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PREVYMIS (letermovir)

Snippet

Sponsor: Anhui Provincial Hospital | Conditions: Cytomegalovirus Infection Reactivation | Status: RECRUITING